ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026
Global, regional, and national burden of maternal hemorrhage from 1990 to 2021, with projections to 2050: Insights from the Global Burden of Disease Study 2021.
Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Global landscape of maternal hemorrhage mortality: a 40-year analysis based on GBD 2021 study.Archives of gynecology and obstetrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveMaternal hemorrhage (MH) remains a significant global health issue. Despite advancements in prevention and management, the burden of MH varies considerably across different regions. This study aimed to assess the current status and temporal trends of MH burden at global, regional, and national levels and to project its future trajectory through 2050.
methodsData were sourced from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021. The study estimated the age-standardized incidence rate (ASIR), the age-standardized death rate (ASDR), the disability-adjusted life years (DALY) rate, and the age-standardized maternal mortality ratio (MMR) with 95% uncertainty intervals (UIs) of MH globally and regionally. Changes in the burden of MH were assessed using the estimated annual percentage change (EAPC). The Bayesian age-period-cohort model was used to forecast disease burden of MH until 2050.
resultsIn 2021, the global burden of MH remained substantial, with an estimated 13.96 million new cases and an ASIR of 176.9 per 100 000 (95% UI: 138.3-225.8). Significant regional disparities were observed. Low Socio-Demographic Index (SDI) regions had the highest ASIR (376 per 100 000; 95% UI: 293.5-484), while high SDI regions reported the lowest (93.1 per 100 000; 95% UI: 73.4-115.8). Western Sub-Saharan Africa exhibited the highest ASIR globally. Additionally, Western Sub-Saharan Africa recorded the highest ASDR (3.5734 per 100 000; 95% UI: 2.6902-4.74), the highest DALY rate (215.2 per 100 000; 95% UI: 163.5-284.7), and the highest MMR (90.4 per 100 000 live births; 95% UI: 68.2-120.6). In contrast, high SDI regions reported the lowest ASDR and DALY rate. From 1990 to 2021, a downward trend was observed in the global ASIR, ASDR, DALY, and MMR for MH, and projections indicated a continued decline in the global burden of MH.
conclusionThe global burden of MH has decreased over the past three decades. However, significant regional disparities persisted. Future initiatives should prioritize the enhancement of healthcare systems in specific regions to further mitigate MH-related morbidity and mortality. Projections suggested a continued global decline in the burden of MH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.